Current concepts in the pathogenesis of Alzheimer's disease
- PMID: 9344401
- DOI: 10.1016/s0002-9343(97)00262-3
Current concepts in the pathogenesis of Alzheimer's disease
Abstract
Alzheimer's disease (AD) affects a large proportion of the increasingly aging population of this country, with prevalence rates as high as 47% for those >85 years old and a total annual cost approaching $70 billion. There is no currently validated test for detection of dementia of the Alzheimer type (DAT). Because of this and the insidious onset of the disease, the diagnosis may be missed by primary care physicians. Cerebral extracellular beta-amyloid deposition as senile plaques and intraneuronal neurofibrillary tangles appear to represent critical processes in the development of AD; however, whether and the extent to which these may also occur in nondemented aging is uncertain. Tangles occur primarily in medial temporal lobe structures (hippocampus, entorhinal cortex, and amygdala), and tangle density correlates with dementia severity. Plaques are diffusely distributed throughout the cerebral cortex, and are the neuropathologic hallmark of the disease. Aging is the primary risk factor for AD. After controlling for differential life expectancy, female sex still appears to be an additional risk factor. There may be a genetic component, in some cases based on family and twin studies. Allelic variation in the apolipoprotein E (Apo E) gene located on chromosome 19 represents another important risk factor. However, the diversity of gene mutations apparently responsible for the various forms of AD suggest that the disease is genetically heterogeneous. AD may be conceptualized as an imbalance between neuronal injury and repair. Oxygen free radicals may be involved in the cross-linking process of beta-amyloid aggregation, and antioxidants may represent a potential intervention. There may be a role for heavy metals in the pathogenesis of AD, but this remains controversial. Work continues toward possibly a cure or prevention, but more likely palliation, of AD, and the results of trials of anti-inflammatory agents, estrogen, and antioxidant therapy are anticipated in the near future.
Comment in
-
The role of estrogen in the treatment and prevention of dementia: introduction.Am J Med. 1997 Sep 22;103(3A):1S-2S. doi: 10.1016/s0002-9343(97)00263-5. Am J Med. 1997. PMID: 9344400 No abstract available.
Similar articles
-
The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):352-6. doi: 10.1136/jnnp.61.4.352. J Neurol Neurosurg Psychiatry. 1996. PMID: 8890772 Free PMC article.
-
Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.JAMA Neurol. 2015 Oct;72(10):1124-31. doi: 10.1001/jamaneurol.2015.1721. JAMA Neurol. 2015. PMID: 26302353 Free PMC article.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
-
Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease.Neurology. 1996 Mar;46(3):707-19. doi: 10.1212/wnl.46.3.707. Neurology. 1996. PMID: 8618671
-
Alzheimer's disease.Semin Neurol. 2006 Nov;26(5):499-506. doi: 10.1055/s-2006-951622. Semin Neurol. 2006. PMID: 17048151 Review.
Cited by
-
Galantamine: a pharmacoeconomic review of its use in Alzheimer's disease.Pharmacoeconomics. 2002;20(13):919-42. doi: 10.2165/00019053-200220130-00005. Pharmacoeconomics. 2002. PMID: 12381243
-
Correlation between hippocampal volumes and proton magnetic resonance spectroscopy of the posterior cingulate gyrus and hippocampi in Alzheimer's disease.Dement Neuropsychol. 2010 Apr-Jun;4(2):109-113. doi: 10.1590/S1980-57642010DN40200006. Dement Neuropsychol. 2010. PMID: 29213672 Free PMC article.
-
Effects of ageing and Alzheimer disease on haemodynamic response function: a challenge for event-related fMRI.Healthc Technol Lett. 2017 Jun 26;4(3):109-114. doi: 10.1049/htl.2017.0005. eCollection 2017 Jun. Healthc Technol Lett. 2017. PMID: 28706728 Free PMC article.
-
The pleiotropic effects of HMG-CoA reductase inhibitors: their role in osteoporosis and dementia.Drugs. 2003;63(2):139-52. doi: 10.2165/00003495-200363020-00002. Drugs. 2003. PMID: 12515562 Review.
-
Microglial VPS35 deficiency impairs Aβ phagocytosis and Aβ-induced disease-associated microglia, and enhances Aβ associated pathology.J Neuroinflammation. 2022 Mar 2;19(1):61. doi: 10.1186/s12974-022-02422-0. J Neuroinflammation. 2022. PMID: 35236374 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical